PHILADELPHIA
,
January 27, 2022
(press release)
–
Graham Partners, a Philadelphia-based private investment firm investing in technology-driven companies that are spurring innovation in advanced manufacturing, is pleased to announce that it has completed six exits, three platform investments, three add-on acquisitions, and two growth investments over the past year. To learn more about the activity at Graham Partners over the past year please click here. In addition to the high level of investment activity, Graham Partners added 15 new team members to the firm across its investment team, ESG, operations, and other areas of the firm, successfully completed a second virtual year of its internship program with over 20 interns, and launched an office renovation project, enhancing its Newtown Square location with new technologies and increased space for collaboration. Notably, three transformative add-on acquisitions were completed in the last two months of the year, furthering Graham’s investment theses in its businesses to add scale, diversification, and breadth. Here’s a brief recap on each of these newly acquired businesses and why we are excited to add them to our family of companies. Most recently ,portfolio company Teamvantage acquired MMD Medical, LLC (“MMD Medical”), an outsourced medical device manufacturer with a complementary set of capabilities, including injection molding, precision machining, and tooling. The business is highly synergistic to the existing Teamvantage platform, which we expect will create a one-stop-shop with differentiated precision manufacturing capabilities serving a broad customer base of tenured, growing customers. The MMD Medical acquisition creates the potential for meaningful value creation by adding scale and capacity, creating operational efficiencies, and expanding access to major medical customers. Earlier in December, portfolio company VPET acquired Canyon Plastics, LLC (“Canyon”), a manufacturer of blow-molded, stretch blow-molded, and injection-molded plastic containers across diversified end markets. Canyon’s attractiveness is underpinned by differentiated design capabilities, premium product offerings, reliable lead times, and proprietary innovation in materials science and is well-aligned with Graham’s original investment thesis in VPET. We believe the business is highly complementary to the existing VPET platform, increasing the overall scale of the business and further diversifying VPET’s product offering, customers, and end markets. In November, portfolio company OptConnect, LLC (“OptConnect”) acquired Premier Wireless Solutions (“PWS”), an Internet of Things (IoT) solutions provider serving the machine-to-machine (M2M) and IoT market with high-margin, specialized solutions. We believe PWS is a transformative add-on acquisition that builds a larger, more diversified platform in the rapidly growing IoT connectivity space. PWS adds significant scale and capabilities, creates cross-selling opportunities, and further diversifies the business into high-growth applications, such as digital signage and medical. Graham also believes there will be significant synergies and cost savings achieved from the combination of the two businesses. Steven Graham, CEO of Graham Partners, states, “2021 was a very productive year for us. In particular, our proprietary sourcing efforts, on both the platform and add-on acquisition front, are yielding attractive opportunities for us to partner with high-growth, founder-owned businesses.” FOR FURTHER INFORMATION CONTACT: Teamvantage / MMD Medical: Joe Heinmiller (jheinmiller@grahampartners.net) VPET/ Canyon: Adam Piatkowski (apiatkowski@grahampartners.net) & Jason Crowl (jcrowl@grahampartners.net) OptConnect / PWS: Rob Newbold (rnewbold@grahampartners.net) Investor Relations: Christina Morin (cmorin@grahampartners.net)
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
